4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

Catalog No. :
ACKHQN120
CAS No. :
57280-22-5
Molecular Formula :
C7H12O3
Molecular Weight :
144.17

IUPAC Name:4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g99%$235.00Login to see priceIn stockInquiry
1000g99%$465.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane
IUPAC Name4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane
MDL No.MFCD16621162
Molecular FormulaC7H12O3
Molecular Weight144.17
SMILESCC1(C)OCC2OC2CO1
InChI KeyGEKNCWQQNMEIMS-UHFFFAOYSA-N
Synonym4,4-Dimethyl-3,5,8-trioxabicyclo(5.1.0)octane | BCP17091 | EC 421-750-9 | SB40516 | EN300-136272 | CS-0043326 | AKOS016007973 | CS1776 | AMY5474 | MFCD16621162 | SY053244 | 4,4-dimethyl-3,5,8-trioxabicyclo[5,1,0]octane | 4,4-Dimethyl-3,5,8-trioxabic-yclo[
CAS No.57280-22-5
PubChem CID11094747

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P261-P264-P272-P280-P302+P352-P305+P351+P338-P333+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACKHQN120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJNRI026 route compound structure diagram
    ACJNRI0261003-83-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKHQN120 route product structure diagram
    ACKHQN12057280-22-5 In Stock
Inquiry

2. ACKHQN120 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJNRI026 route compound structure diagram
    ACJNRI0261003-83-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKHQN120 route product structure diagram
    ACKHQN12057280-22-5 In Stock
Inquiry

Comments (0)